Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 3Phase NA 2Phase 1 2Phase 4 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Endometrial Neoplasms 1Castration Resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma, Ductal 1

Interventions

Rocuronium 2Ofloxacin 2Mitomycin 25-aminolevulinic acid hexyl ester 2remimazolam 1penpulimab 1pembrolizumab 1mebeverine 1lornoxicam 1enfortumab vedotin 1disitamab vedotin 1Ultrasonography 1Trimethoprim, Sulfamethoxazole Drug Combination 1Tobacco Use Cessation Devices 1Tamsulosin 1Sugammadex 1Specimen Handling 1Psychiatric Rehabilitation 1Propofol 1Polymerase Chain Reaction 1Nitrofurantoin 1Neuromuscular Blockade 1Neuroleptanalgesia 1Nephroureterectomy 1Neostigmine 1Midazolam 1Metformin 1Mepivacaine 1Magnetic Resonance Spectroscopy 1Levofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Urinary Bladder Neoplasms × Specimen Handling × Clear all
NCT06764095 2026-02-12

Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial

Mayo Clinic

Phase 4 Recruiting
75 enrolled
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡